Morton Community Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,489
Closed -$4.73M 116
2025
Q4
$4.73M Buy
25,489
+849
+3% +$149K 1.02% 37
2025
Q3
$4.06M Buy
24,640
+1,265
+5% +$191K 0.94% 46
2025
Q2
$3.27M Buy
23,375
+1,140
+5% +$160K 0.81% 71
2025
Q1
$3.27M Buy
22,235
+1,072
+5% +$155K 0.86% 67
2024
Q4
$2.77M Buy
21,163
+1,203
+6% +$168K 0.73% 78
2024
Q3
$3.11M Buy
19,960
+402
+2% +$64.9K 0.81% 76
2024
Q2
$3.05M Buy
19,558
+3,285
+20% +$494K 0.86% 63
2024
Q1
$2.2M Buy
+16,273
New +$2.15M 0.63% 87

Other funds holding AZN

Morton Community Bank's AZN Position: Q1 2026 in Review

Morton Community Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 25,489 shares — an estimated $4.73M sold.

Morton Community Bank first reported a position in AZN in Q1 2024 and held it in 8 quarters. The position peaked at $4.73M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Morton Community Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Morton Community Bank sold 25,489 AstraZeneca shares in Q1 2026, an estimated $4.73M.
  • Morton Community Bank first reported a position in AstraZeneca in Q1 2024 and held it in 8 quarters.
  • Morton Community Bank's AstraZeneca position peaked at $4.73M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Morton Community Bank's 13F filing for Q1 2026, filed 14 May 2026.